business
An experimental Alzheimer’s drug shows some promise as researchers hunt new approaches
By Associated Press at Odessa American (oaoa.com)
· July 14, 2026
· 5 min read
These brain scan images provided by Biogen show how high levels of Alzheimer’s-related tau protein, in red, dropped in a recipient of the company’s experimental drug diranersen. (Biogen via AP)
By LAURAN NEERGAARD
AP Medical Writer
WASHINGTON An experimental drug might help slow early Alzheimer’...
Key takeaway “This is really quite promising if it were to hold up” in that next-step testing, said Jessica Langbaum of the Banner Alzheimer’s Institute in Phoenix, who wasn’t involved with Biogen’s study.
Why this matters in The Odessa
The potential breakthrough in Alzheimer's treatment has significant implications for the Odessa community, where many families are affected by the disease. As the population in Ector County ages, the need for effective treatments and support services will only grow. The experimental drug diranersen, which targets the tau protein, offers a new avenue of hope for local residents living with Alzheimer's. If proven effective in larger studies, this treatment could improve the quality of life for many in the Permian Basin area. Additionally, the renewed focus on tau mechanisms and other novel approaches could attract research investments and expertise to the region, potentially bolstering the local healthcare sector and providing access to cutting-edge treatments for area residents. As the medical community continues to explore new ways to combat Alzheimer's, Odessa residents will be watching closely for developments that could bring relief to those affected by this devastating disease.
About this story
Original reporting by Odessa American (oaoa.com) . The Odessa surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit Odessa American (oaoa.com) . Have a tip or correction? Contact our newsroom .
Category: business ·
Published: July 14, 2026 ·
Source: Odessa American (oaoa.com) ·
Reading time: 5 min
Get more The Odessa stories like this
Free weekly briefing covering business and other local news. Curated by our editorial team. No spam.
By subscribing you agree to our privacy policy . Unsubscribe anytime.
Frequently asked about this story
What is this story about? These brain scan images provided by Biogen show how high levels of Alzheimer’s-related tau protein, in red, dropped in a recipient of the company’s experimental drug diranersen. (Biogen via AP)
By LAURAN NEERGAARD
AP Medical Writer
WASHINGTON An experimental drug might help slow early Alzheimer’...
When was this published? This article was first published on July 14, 2026 by Odessa American (oaoa.com) and curated for The Odessa readers.
Who reported this story? This story was reported by Associated Press at Odessa American (oaoa.com). To learn more about how The Odessa selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more business coverage from The Odessa, or browse our daily briefing and topic hubs .
← Back to all news
More business →
Today’s briefing
Subscribe to newsletter